<DOC>
	<DOCNO>NCT01142531</DOCNO>
	<brief_summary>CT study consider bronchial dimension chronic obstructive pulmonary disease ( COPD ) conduct without control bronchodilation . Some data however suggest total lung capacity ( CT scan perform full inspiration ) increase individual affect chronic spontaneous bronchoconstriction may decrease bronchodilatation . Furthermore , study assess effect bronchodilation CT scan parameter reflect airway remodelling emphysema extent COPD patient . This prospective study whose purpose assess effect bronchodilation lung CT scan pulmonary function test ( PFT ) COPD patient .</brief_summary>
	<brief_title>Effects Bronchodilation Computed Tomography ( CT ) Parameters Reflecting Airways Remodelling , Pulmonary Emphysema Extent .</brief_title>
	<detailed_description>Patients : COPD patient age 40 year , smoke history &gt; 10 pack-years ( PY ) post-bronchodilator forced expiratory volume one second vital capacity ratio ( FEV1/VC ) &lt; 0.7 include . Exclusion criterion : COPD exacerbation respiratory infection 4 week begin study , concomitant pulmonary disease ( tuberculosis , significant bronchiectasis , lung cancer ) , pulmonary resection , active malignancy malignancy organ system within past 5 year . Procedures : At Visit 1 , obtain write informed consent patient , medical history , smoke status patient 's treatment collect . They ask discontinue bronchodilator therapy follow , pulmonary function test ( PFT ) CT scan initially evaluated medication wash-out period Visit 2 : - Short act a2 agonist anticholinergic : 8 wash-out - Long acting a2 agonist : 12h wash-out - Long acting anticholinergic : 48h wash-out - Theophylline preparation : 48h wash-out - Antileucotrienes : 48h wash-out At visit 2 , PFT perform , include vital capacity ( VC ) , force vital capacity ( FVC ) , functional residual capacity ( FRC ) , total lung capacity ( TLC ) , residual volume ( RV ) , forced expiratory volume one second ( FEV1 ) , diffusion lung capacity carbon monoxide ( DLCO ) , alveolar volume ( VA ) measurement ( either absolute value percentage predict value ) . A first CT scan perform use follow technique : - Supine CT scan full inspiration . - Acquisition parameter : ( Topogram 35 mA 120 kV 512 mm length ) 90 quality ref mAs care-dose ON 120 kV Pitch 1.4 Rotation time 0.33 Acquired image 64 x 0.6 mm - Reconstructions parameter : B60f 1mm-thick every 0.7 mm B20f 1mm-thick every 10.0 mm B35f 1mm-thick every 0.7 mm B60f 5mm-thick every 5.0 mm B35f 5mm-thick every 5.0 mm After initial PFT CT scan , patient receive 80 µg ipratropium bromide ( = 4X20µg Atrovent , via Metered-Dose Inhaler + spacer , 30 second dose ) 60 minute later , 400 µg salbutamol ( =4X100 µg Ventolin ) . A second PFT perform 30 min salbutamol inhalation , follow second CT Scan . Data analysis : - Emphysema index : B20f reconstruction , calculation RA960 use Pulmo CT software . - Airway index : B60f reconstruction ( 1mm-thick every 0.7 mm ) , calculation luminal area wall area several bronchus . Statistical analysis : Comparisons CT parameter value derive value ( example : wall area airway area ratio ) reflect emphysema airway remodelling , bronchodilation . Correlations PFT value derive value .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Airway Remodeling</mesh_term>
	<criteria>age 40 Smoking history &gt; 10 packyears post bronchodilator FEV1/VC &lt; 0.7 COPD exacerbation infection 4 week study Concomitant pulmonary disease ( tuberculosis , significant bronchiectasis , lung cancer ) pulmonary resection active malignancy malignancy organ system within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>